ArticleFrontiers in human neuroscience2025
Loudness dependence of the auditory evoked potential: temporal stability, associations to sociodemographic variables, and functional significance-implications for clinical research.
Article in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Hormonal contraceptives and EEG biomarkers for antidepressant treatment response in women.Communications medicine · 2026Article
- Hormonal contraceptive use is associated with reduced central serotonergic activity indexed by the loudness dependence of auditory evoked potentials.Frontiers in human neuroscience · 2025Article
- Loudness dependence of auditory evoked potentials reflects trait anxiety and harm avoidance in healthy adults: an exploratory study.Frontiers in human neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The loudness dependence of the auditory evoked potential (LDAEP) has been suggested as a biomarker for central serotonergic function, and as such a proxy for serotonin related psychiatric symptomatology and intervention outcome, particularly in depression. This study aims to explore LDAEP characteristics in a large healthy population by assessing its test-retest reliability and examining associations with sociodemographic variables, psychological distress, and performance-based cognitive function. Methods: Our sample included 100 healthy adults whose LDAEP was measured and correlated with age, sex, self-reported psychological distress, and cognitive performance. Results: Participants examined twice ( Discussion: These results underline LDAEP's reliability as a biomarker over time, but also highlight age, sex and hormonal contraceptive use as significant factors influencing the LDAEP. Future research in clinical population should take these results into account, with an emphasis on providing the necessary sample sizes for relevant sub-group analyses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.